Cargando…
Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment
OBJECTIVE: The metabolic influence of gut microbiota plays a pivotal role in the pathogenesis of cardiometabolic diseases. Antibiotics affect intestinal bacterial diversity, and long-term usage has been identified as an independent risk factor for atherosclerosis-driven events. The aim of this study...
Autores principales: | Kappel, Ben Arpad, De Angelis, Lorenzo, Heiser, Michael, Ballanti, Marta, Stoehr, Robert, Goettsch, Claudia, Mavilio, Maria, Artati, Anna, Paoluzi, Omero A., Adamski, Jerzy, Mingrone, Geltrude, Staels, Bart, Burcelin, Remy, Monteleone, Giovanni, Menghini, Rossella, Marx, Nikolaus, Federici, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183232/ https://www.ncbi.nlm.nih.gov/pubmed/32251665 http://dx.doi.org/10.1016/j.molmet.2020.100976 |
Ejemplares similares
-
Lipidomics and metabolomics signatures of SARS-CoV-2 mediators/receptors in peripheral leukocytes, jejunum and colon
por: Mayneris-Perxachs, Jordi, et al.
Publicado: (2021) -
Non‐targeted metabolomics identify polyamine metabolite acisoga as novel biomarker for reduced left ventricular function
por: Puetz, Andreas, et al.
Publicado: (2021) -
Alterations in Rev-ERBα/BMAL1 ratio and glycated hemoglobin in rotating shift workers: the EuRhythDia study
por: Rizza, Stefano, et al.
Publicado: (2021) -
Impact of light therapy on rotating night shift workers: the EuRhythDia study
por: Rizza, Stefano, et al.
Publicado: (2022) -
Human and mouse non‐targeted metabolomics identify 1,5‐anhydroglucitol as SGLT2‐dependent glycemic marker
por: Kappel, Ben A., et al.
Publicado: (2021)